Global Hemp Group Inc.

Equities

GHG

CA37953Y2033

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange Other stock markets 14:42:31 2024-06-27 EDT			5-day change	1st Jan Change
0.03 ^CAD	0.00%		-33.33%	-53.85%

05-30	Global Hemp Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
05-16	Global Hemp Group Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Global Hemp Group Inc. Reports Earnings Results for the Full Year Ended September 30, 2020

January 27, 2021

Global Hemp Group Inc. announced earnings results for the full year ended September 30, 2020. For the full year, the company announced sales was CAD 28,876 compared to CAD 2,588 a year ago. Net loss was CAD 1.269 million compared to CAD 2.671 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.02 a year ago.

Latest news about Global Hemp Group Inc.

Global Hemp Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-30	CI
Global Hemp Group Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	05-15	CI
Global Hemp Group Inc. cancelled the transaction announced on January 15, 2024	01-15	CI
Global Hemp Group Inc. announced that it expects to receive CAD 0.75 million in funding	01-14	CI
Global Hemp Group Inc. Announces Resignation of Stephen Barnhill Jr. as Director	01-12	CI
Global Hemp Group Inc. Appoints Yousef Kamhiyah as Chief Financial Officer	01-12	CI
Global Hemp Group Inc. Announces Resignation of Veronique Laberge as CFO	01-08	CI
Global Hemp Group Inc. Announces Resignation of Veronique Laberge as Director	01-08	CI
Global Hemp Group Inc. announced that it expects to receive CAD 0.448537 million in funding	23-10-15	CI
Global Hemp Group Inc. Executes Letter of Intent with B-Organic R&D Corp. to Establish 50% Joint Venture with its Patented Bioactive Lipid Agents Technology	23-10-11	CI
Global Hemp Group Inc. Appoints Ramsey Douglas as Director	23-10-03	CI
Global Hemp Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-28	CI
Global Hemp Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-29	CI
Global Hemp Group Inc. announced that it has received CAD 1 million in funding	23-04-19	CI
Global Hemp Group Inc. Appoints Jeff Nagel as Product Manufacturing Advisor	23-03-29	CI
Global Hemp Group Announces the Appointment of Dr. Herbert Fritsche to the Advisory Board as Its Chief Scientific Advisor	23-03-22	CI
Global Hemp Group Inc. Announces Executive Changes	23-03-20	CI
Global Hemp Group Inc. Announces Management Changes	23-03-20	CI
Global Hemp Group Inc. announced that it expects to receive CAD 0.75 million in funding	23-03-07	CI
Global Hemp Group Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-03-01	CI
Global Hemp Group Inc. Appointment of Arelio Useche and Veronique Laberge as Board of Directors	23-02-14	CI
Global Hemp Group Inc. Auditor Raises 'Going Concern' Doubt	23-02-05	CI
Global Hemp Group Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-02-05	CI
Revitalize Earth cancelled the acquisition of Global Hemp Group Inc. (CNSX : GHG) in a reverse merger transaction.	23-01-02	CI
Global Hemp Group Inc. Announces Resignation of Michel Lebeuf as Director	22-11-04	CI

Chart Global Hemp Group Inc.

Duration

Period

More charts

Company Profile

Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Companyâs has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.

Sector

Healthcare Facilities & Services

Calendar

2024-08-26 - Q3 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Farming

	1st Jan change	Capi.
GLOBAL HEMP GROUP INC.	-53.85%	532K
AYR WELLNESS INC.	+11.11%	223M
ASCEND WELLNESS HOLDINGS, INC.	-3.09%	200M
ORGANIGRAM HOLDINGS INC.	+22.67%	160M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
BAKHU HOLDINGS, CORP.	+300.00%	121M
JUSHI HOLDINGS INC.	+21.30%	110M
INTERCURE LTD.	+69.90%	95.96M
THE CANNABIST COMPANY HOLDINGS INC.	-57.00%	90.83M
4FRONT VENTURES CORP.	-15.38%	73.56M

Medical Farming